Mark H. Einstein, M.D., M.S.
Albert Einstein College of Medicine
Albert Einstein Cancer Center
Dr. Mark Einstein is Director of Clinical Research and an Attending Physician in the Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Women’s Health, at Albert Einstein College of Medicine's Albert Einstein Cancer Center, Montefiore Medical Center and North Central Bronx Health Network in Bronx, New York. Dr. Einstein’s primary research interests focus on the pathogenesis and therapy for cervical cancer. Specifically, he is studying the numerous pathways involved in the malignant transformation of the cervix starting from the causative infectious agent- Human Papillomavirus (HPV). He has been funded to investigate these immune pathways as well as genetic variations and genetic susceptibility loci that may make women prone to develop cervical cancer. He has been heading multiple multi-institutional clinical trials targeting HPV and cervical cancer. He recently participated in the development of the American Cancer Society recommendations for screening and for the use of HPV vaccines. Dr. Einstein is also a consultant to the World Health Organization (WHO), developing their modules on the immunologic basis of HPV vaccines.
Dr. Einstein is Chair of the National Cervical Cancer Public Education Campaign of the Gynecologic Cancer Foundation (GCF) and serves on the GCF’s Board of Directors. He is a Fellow of the American College of Obstetrics and Gynecology (ACOG), American College of Surgeons (ACS) and he is a peer-reviewer for numerous journals. He has received funding for cervical cancer-related translational research from the NIH, GCF, ACOG and the Berlex Foundation. Most recently, he has been funded by and named an American Cancer Society Research Scholar.
